NSAV Competitors

Innovative Industrial Properties (NYSE:IIPR) and NSAV (OTCMKTS:NSAV) are both finance companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

Insider and Institutional Ownership

74.9% of Innovative Industrial Properties shares are held by institutional investors. 2.9% of Innovative Industrial Properties shares are held by insiders. Comparatively, 0.2% of NSAV shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Innovative Industrial Properties and NSAV's revenue, earnings per share (EPS) and valuation.

Innovative Industrial Properties has higher revenue and earnings than NSAV.

Volatility & Risk

Innovative Industrial Properties has a beta of 1.52, meaning that its share price is 52% more volatile than the S&P 500. Comparatively, NSAV has a beta of 3.85, meaning that its share price is 285% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Innovative Industrial Properties and NSAV, as provided by MarketBeat.com.

Innovative Industrial Properties currently has a consensus price target of $192.4286, suggesting a potential upside of 6.43%. Given Innovative Industrial Properties' higher possible upside, equities research analysts plainly believe Innovative Industrial Properties is more favorable than NSAV.

Profitability

This table compares Innovative Industrial Properties and NSAV's net margins, return on equity and return on assets.

Summary

Innovative Industrial Properties beats NSAV on 8 of the 9 factors compared between the two stocks.

GrowGeneration (NASDAQ:GRWG) and NSAV (OTCMKTS:NSAV) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

Insider and Institutional Ownership

51.3% of GrowGeneration shares are held by institutional investors. 13.6% of GrowGeneration shares are held by insiders. Comparatively, 0.2% of NSAV shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares GrowGeneration and NSAV's revenue, earnings per share (EPS) and valuation.

GrowGeneration has higher revenue and earnings than NSAV.

Volatility & Risk

GrowGeneration has a beta of 3.09, meaning that its share price is 209% more volatile than the S&P 500. Comparatively, NSAV has a beta of 3.85, meaning that its share price is 285% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for GrowGeneration and NSAV, as provided by MarketBeat.com.

GrowGeneration currently has a consensus price target of $49.5714, suggesting a potential upside of 9.33%. Given GrowGeneration's higher possible upside, equities research analysts plainly believe GrowGeneration is more favorable than NSAV.

Profitability

This table compares GrowGeneration and NSAV's net margins, return on equity and return on assets.

Summary

GrowGeneration beats NSAV on 8 of the 9 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and NSAV (OTCMKTS:NSAV) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

Earnings and Valuation

This table compares 22nd Century Group and NSAV's revenue, earnings per share (EPS) and valuation.

Profitability

This table compares 22nd Century Group and NSAV's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for 22nd Century Group and NSAV, as provided by MarketBeat.com.

Summary

22nd Century Group beats NSAV on 1 of the 1 factors compared between the two stocks.

KushCo (OTCMKTS:KSHB) and NSAV (OTCMKTS:NSAV) are both small-cap multi-sector conglomerates companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

Valuation and Earnings

This table compares KushCo and NSAV's revenue, earnings per share (EPS) and valuation.

NSAV has lower revenue, but higher earnings than KushCo.

Profitability

This table compares KushCo and NSAV's net margins, return on equity and return on assets.

Risk and Volatility

KushCo has a beta of 1.91, meaning that its stock price is 91% more volatile than the S&P 500. Comparatively, NSAV has a beta of 3.85, meaning that its stock price is 285% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for KushCo and NSAV, as provided by MarketBeat.

KushCo presently has a consensus price target of $1.8750, suggesting a potential upside of 65.20%. Given KushCo's higher possible upside, research analysts plainly believe KushCo is more favorable than NSAV.

Insider & Institutional Ownership

0.0% of KushCo shares are held by institutional investors. 17.3% of KushCo shares are held by insiders. Comparatively, 0.2% of NSAV shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

KushCo beats NSAV on 5 of the 9 factors compared between the two stocks.

NSAV (OTCMKTS:NSAV) and Terra Tech (OTCMKTS:TRTC) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, dividends, risk and institutional ownership.

Earnings and Valuation

This table compares NSAV and Terra Tech's top-line revenue, earnings per share and valuation.

NSAV has higher earnings, but lower revenue than Terra Tech.

Profitability

This table compares NSAV and Terra Tech's net margins, return on equity and return on assets.

Volatility & Risk

NSAV has a beta of 3.85, indicating that its share price is 285% more volatile than the S&P 500. Comparatively, Terra Tech has a beta of 2.4, indicating that its share price is 140% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings for NSAV and Terra Tech, as reported by MarketBeat.com.

Institutional & Insider Ownership

0.1% of Terra Tech shares are owned by institutional investors. 0.2% of NSAV shares are owned by company insiders. Comparatively, 6.7% of Terra Tech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

NSAV beats Terra Tech on 4 of the 7 factors compared between the two stocks.

NSAV (OTCMKTS:NSAV) and General Cannabis (OTCMKTS:CANN) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, dividends, risk and institutional ownership.

Volatility & Risk

NSAV has a beta of 3.85, indicating that its share price is 285% more volatile than the S&P 500. Comparatively, General Cannabis has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500.

Earnings and Valuation

This table compares NSAV and General Cannabis' top-line revenue, earnings per share and valuation.

NSAV has higher earnings, but lower revenue than General Cannabis.

Analyst Recommendations

This is a summary of current ratings for NSAV and General Cannabis, as reported by MarketBeat.com.

Profitability

This table compares NSAV and General Cannabis' net margins, return on equity and return on assets.

Summary

NSAV beats General Cannabis on 3 of the 4 factors compared between the two stocks.